Slover Peter T 4
4 · ANADYS PHARMACEUTICALS INC · Filed Dec 15, 2010
Insider Transaction Report
Form 4
Slover Peter T
VP, Finance and Operations
Transactions
- Award
Stock Option (Right to Buy)
2010-12-13+51,750→ 51,750 totalExercise: $1.02From: 2011-12-13Exp: 2020-12-12→ Common Stock (51,750 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest and become exercisable one year from the date of grant with the remaining shares subject to the option vesting in equal installments over the next three years such that all shares subject to the option will be fully vested and exercisable as of December 13, 2014.